Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Omeros CorporationNASDAQ: OMER
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin at 91.7%
Gross margin was 91.7% in Q1 FY2026. On a trailing-twelve-month basis it was -12.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
No Gross Margin data reported for this period type.
Gross Margin vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 gross margin of -12.4% is the 7th highest of the 8 companies compared; the peer median is 88.1%.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 116.4% | +166.6 pp | +862.2 pp | |
| LTM Jun 2026 | 99.4% | +15.9 pp | +23.5 pp | |
| LTM Jun 2026 | 94.0% | -6.0 pp | -4.0 pp | |
| LTM Mar 2026 | 88.1% | +17.9 pp | +0.3 pp | |
| LTM Mar 2026 | 69.9% | +7.9 pp | -24.0 pp | |
| LTM Jun 2026 | 43.3% | -18.0 pp | +112.9 pp | |
| LTM Mar 2026 | -12.4% | — | — | |
| LTM Mar 2026 | -105.7% | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding OMER) | 88.1% | +11.9 pp | +11.9 pp | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.39M | 0 | 0 | 0 | 0 |
| Gross Profit | (1.39M) | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 118.78M | 112.72M | 114.87M | 119.52M | 81.3M |
| Selling, General & Admin | 53.46M | 50.67M | 49.66M | 49.74M | 41.5M |
| Operating Expenses | 172.23M | 163.39M | 164.53M | 169.26M | 122.8M |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| EBITDA | (170.49M) | (158.38M) | (143.16M) | (157M) | (1.83M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (173.62M) | (163.39M) | (164.53M) | (169.26M) | (122.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17.93K | 4.06M | 16.34M | 11.3M | 5.06M |
| Interest Expense | 19.67M | 22.7M | 30.84M | 24.68M | 0 |
| Other Income / Expenses | (17.93M) | (18.64M) | (10.39M) | (13.37M) | 120M |
| Income Before Tax | (191.55M) | (182.03M) | (174.92M) | (182.63M) | (2.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 2.01M |
| Net Income | (111.41M) | 47.42M | (117.81M) | (156.82M) | (3.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| EPS (Diluted) | 3.12 | 0.46 | (1.88) | (2.70) | (0.05) |
| Weighted Avg Shares | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
| Weighted Avg Shares (Diluted) | 62.34M | 62.74M | 62.74M | 58.17M | 63.51M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.